197 related articles for article (PubMed ID: 6413742)
21. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
22. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes.
Rabinowich H; Cohen R; Bruderman I; Steiner Z; Klajman A
Cancer Res; 1987 Jan; 47(1):173-7. PubMed ID: 3491673
[TBL] [Abstract][Full Text] [Related]
23. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
24. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non-specific killer T cells capable of lysing autologous tumor.
Uchida A; Moore M; Klein E
Int J Cancer; 1988 May; 41(5):651-6. PubMed ID: 2966771
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with phytohemagglutinin.
Mazumder A; Grimm EA; Rosenberg SA
J Immunol; 1983 Feb; 130(2):958-64. PubMed ID: 6848602
[TBL] [Abstract][Full Text] [Related]
26. [The cytotoxicity of malignant pleural effusion lymphocytes and LAK cells against autologous tumor cells].
Guo Y; Xing Z
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr; 18(2):80-2, 127. PubMed ID: 7553955
[TBL] [Abstract][Full Text] [Related]
27. Lysis of fresh natural killer-resistant tumor cells by lectin-activated syngeneic and allogeneic murine splenocytes.
Mazumder A; Rosenstein M; Rosenberg SA
Cancer Res; 1983 Dec; 43(12 Pt 1):5729-34. PubMed ID: 6640524
[TBL] [Abstract][Full Text] [Related]
28. Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors.
Allavena P; Zanaboni F; Rossini S; Merendino A; Bonazzi C; Vassena L; Mangioni C; Mantovani A
J Natl Cancer Inst; 1986 Oct; 77(4):863-8. PubMed ID: 3489856
[TBL] [Abstract][Full Text] [Related]
29. A study of the cytotoxicity of malignant pleural effusion lymphocytes and LAK cells against autologous tumor cells.
Guo YS; Xing ZL
Chin Med J (Engl); 1994 Dec; 107(12):903-5. PubMed ID: 7882727
[TBL] [Abstract][Full Text] [Related]
30. Profile of T-cell receptor V beta gene usage of cytotoxic T cells induced by intrapleural administration of a streptococcal preparation, OK432, in malignant effusions.
Miyahara E; Yamaguchi Y; Hihara J; Noma K; Toge T
J Exp Ther Oncol; 1996 Jul; 1(4):242-50. PubMed ID: 9414411
[TBL] [Abstract][Full Text] [Related]
31. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.
Lotze MT; Grimm EA; Mazumder A; Strausser JL; Rosenberg SA
Cancer Res; 1981 Nov; 41(11 Pt 1):4420-5. PubMed ID: 6975652
[TBL] [Abstract][Full Text] [Related]
32. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of cytotoxicity to autologous tumor cells by the regional lymph node cells of patients with primary lung cancer.
Kadoyama C; Kimura H; Yamaguchi Y
Jpn J Clin Oncol; 1987 Mar; 17(1):29-39. PubMed ID: 2951535
[TBL] [Abstract][Full Text] [Related]
34. Autologous tumor killing and natural cytotoxic activity of tumor-associated macrophages in cancer patients.
Yanagawa E; Uchida A; Moore M; Micksche M
Cancer Immunol Immunother; 1985; 19(3):163-7. PubMed ID: 2408742
[TBL] [Abstract][Full Text] [Related]
35. Natural cytotoxicity in humans: susceptibility of freshly isolatd tumor cells to lysis.
Vose BM; Moore M
J Natl Cancer Inst; 1980 Aug; 65(2):257-63. PubMed ID: 6157044
[TBL] [Abstract][Full Text] [Related]
36. Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung.
Fujisawa T; Yamaguchi Y
Cancer; 1997 Feb; 79(3):474-81. PubMed ID: 9028357
[TBL] [Abstract][Full Text] [Related]
37. Generation of cytotoxic factor by human large granular lymphocytes during interaction with autologous tumor cells: lysis of fresh human tumor cells.
Uchida A; Klein E
J Natl Cancer Inst; 1988 Nov; 80(17):1398-403. PubMed ID: 3262773
[TBL] [Abstract][Full Text] [Related]
38. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y
J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
[TBL] [Abstract][Full Text] [Related]
39. Interferon-alpha in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agents.
Kaneto E; Sasaki H; Tamura I; Kurimura O; Kurimura T
Biken J; 1983 Jun; 26(2):99-102. PubMed ID: 6318725
[TBL] [Abstract][Full Text] [Related]
40. Intrapleural administration of OK432 in cancer patients: activation of NK cells and reduction of suppressor cells.
Uchida A; Micksche M
Int J Cancer; 1983 Jan; 31(1):1-5. PubMed ID: 6219961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
